January 2018 - Systemic Connections: How Diet and Microbiome Composition Influence Internal Networks, Part I
Type 2 diabetes is a condition that is typically classified as a disorder of the endocrine system and glucagon-like peptide-1 (GLP-1) is a hormone that plays a key role in the regulation of insulin. Exenatide is a drug that is used in the pharmacological management of type 2 diabetes; it is a glucagon-like peptide-1 agonist medication.
In a recent issue of Lancet, Dr. Bland read with great interest an article describing the results of a clinical trial in which Exenatide was . . .